Clinical trial
Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety…
NCT00238719 · Wyeth is now a wholly owned subsidiary of Pfizer, Industry · Completed
Key facts
| NCT number | NCT00238719 |
|---|---|
| Title | Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder |
| Official title | A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine ER In Children and Adolescent Outpatients With Social Anxiety Disorder |
| Lead sponsor | Wyeth is now a wholly owned subsidiary of Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Social Anxiety Disorder |
| Intervention type | Drug |
| Interventions | Venlafaxine ER |
| Enrollment | 293 |
| Start date | Dec 1, 1999 |
| Completion | Jun 1, 2003 |
| First posted | Oct 13, 2005 |
| Last update posted | May 19, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: